Affibody is a biotechnology company developing next generation radiopharmaceuticals based on our proprietary Affibody® platform
Affibody is strategically focused on advancing our pipeline of radioligand therapeutics that offer a competitive advantage and significant opportunities to benefit cancer patients. Our pipeline also includes partnership programs in immunology.
event
27 Mar
AAD Annual Meeting 2026 March 27-31, 2026, Denver, USA
event
12 Jan
JP Morgan Healthcare Conference 2026 January 12-15, 2026, San Francisco, USA
There are currently no posts in the reports and events archive.
Regulatory
2026-01-20
Affibody Carries Out Fully Guaranteed Rights Issue of SEK 307 Million
It is the competence and the engagement of all coworkers that make Affibody an inspiring and exciting place to work at. We know we reach much further in innovation, efficiency, and quality by having a work place where we as coworkers care for each other, are ambitious and know and value our own contribution to the end result.
